These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22777078)

  • 1. Confirmatory factor analysis of the ADNI Neuropsychological Battery.
    Park LQ; Gross AL; McLaren DG; Pa J; Johnson JK; Mitchell M; Manly JJ;
    Brain Imaging Behav; 2012 Dec; 6(4):528-39. PubMed ID: 22777078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical signatures of cognition and their relationship to Alzheimer's disease.
    Gross AL; Manly JJ; Pa J; Johnson JK; Park LQ; Mitchell MB; Melrose RJ; Inouye SK; McLaren DG;
    Brain Imaging Behav; 2012 Dec; 6(4):584-98. PubMed ID: 22718430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.
    Gibbons LE; Carle AC; Mackin RS; Harvey D; Mukherjee S; Insel P; Curtis SM; Mungas D; Crane PK;
    Brain Imaging Behav; 2012 Dec; 6(4):517-27. PubMed ID: 22644789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal change in neuropsychological performance using latent growth models: a study of mild cognitive impairment.
    Johnson JK; Gross AL; Pa J; McLaren DG; Park LQ; Manly JJ;
    Brain Imaging Behav; 2012 Dec; 6(4):540-50. PubMed ID: 22562439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
    Crane PK; Carle A; Gibbons LE; Insel P; Mackin RS; Gross A; Jones RN; Mukherjee S; Curtis SM; Harvey D; Weiner M; Mungas D;
    Brain Imaging Behav; 2012 Dec; 6(4):502-16. PubMed ID: 22782295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor analyses of the ADNI neuropsychological battery: An examination of diagnostic and longitudinal invariance.
    Chang M; Brainerd CJ
    Neuropsychology; 2021 May; 35(4):434-450. PubMed ID: 34043393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI.
    Skinner J; Carvalho JO; Potter GG; Thames A; Zelinski E; Crane PK; Gibbons LE;
    Brain Imaging Behav; 2012 Dec; 6(4):489-501. PubMed ID: 22614326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of a Novel Touch Screen Tablet-Based Assessment for Mild Cognitive Impairment and Probable AD in Older Adults.
    Huang YP; Singh A; Chen S; Sun FJ; Huang CR; Liu SI
    Assessment; 2019 Dec; 26(8):1540-1553. PubMed ID: 29251514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological Equivalence of the Clinical Diagnosis of Mild Cognitive Impairment in the National Alzheimer's Coordinating Center Uniform Data Set and Alzheimer's Disease Neuroimaging Initiative.
    Kiselica AM; Benge JF;
    Dement Geriatr Cogn Disord; 2021; 50(3):231-236. PubMed ID: 34186536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancy-Based Evidence for Loss of Thinking Abilities (DELTA): Development and Validation of a Novel Approach to Identifying Cognitive Changes.
    Asken BM; Thomas KR; Lee A; Davis JD; Malloy PF; Salloway SP; Correia S
    J Int Neuropsychol Soc; 2020 May; 26(5):464-479. PubMed ID: 31822312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild to moderate decrease in eGFR and cognitive decline in older adults.
    Grasing M; Kennedy K; Sarnak MJ; Burns JM; Gupta A
    Nephrol Dial Transplant; 2022 Jul; 37(8):1499-1506. PubMed ID: 34289074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: the VMCI-Tuscany Study.
    Salvadori E; Poggesi A; Pracucci G; Inzitari D; Pantoni L;
    J Alzheimers Dis; 2015; 43(4):1313-23. PubMed ID: 25147116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-Positive Error Rates for Reliable Digit Span and Auditory Verbal Learning Test Performance Validity Measures in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease.
    Loring DW; Goldstein FC; Chen C; Drane DL; Lah JJ; Zhao L; Larrabee GJ;
    Arch Clin Neuropsychol; 2016 Jun; 31(4):313-31. PubMed ID: 27084732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REMEDES for Alzheimer-R4Alz Battery: Design and Development of a New Tool of Cognitive Control Assessment for the Diagnosis of Minor and Major Neurocognitive Disorders.
    Poptsi E; Tsardoulias E; Moraitou D; Symeonidis AL; Tsolaki M
    J Alzheimers Dis; 2019; 72(3):783-801. PubMed ID: 31640100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.
    Lim YY; Ellis KA; Harrington K; Kamer A; Pietrzak RH; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Ames D; Maruff P;
    Neuropsychology; 2013 May; 27(3):322-332. PubMed ID: 23688214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between small cerebral white matter lesions and cognitive function in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Makino T; Umegaki H; Suzuki Y; Yanagawa M; Nonogaki Z; Nakashima H; Kuzuya M
    Geriatr Gerontol Int; 2014 Oct; 14(4):819-26. PubMed ID: 24215176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors.
    Cui Y; Liu B; Luo S; Zhen X; Fan M; Liu T; Zhu W; Park M; Jiang T; Jin JS;
    PLoS One; 2011; 6(7):e21896. PubMed ID: 21814561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.